co-condensation synthesis of salicylaldimine calcium complex containing mesoporous silica nanoparticles as carriers for drug release
Duihai Tang , Weiran Zhang , Yifan Wang , Jing Miao , Zhen’an Qiao , Qisheng Huo , Lirong Zhang
Chemical Research in Chinese Universities ›› 2014, Vol. 30 ›› Issue (4) : 531 -537.
co-condensation synthesis of salicylaldimine calcium complex containing mesoporous silica nanoparticles as carriers for drug release
A series of functional mesoporous silica nanoparticles(MSNs) was synthesized by a one-step simple synthesis approach involving co-condensation of tetraethoxysilane(TEOS) and salicylaldimine ligand(Sal-Si) in the presence of cetyltrimethylammonium chloride(CTAC) under basic conditions. The target MSNs with different sizes (50, 100 and 200 nm, respectively) were obtained. Furthermore, the Ca2+ cations were also introduced into MSNs. The prepared nanoparticles were characterized by means of infrared(IR) spectra, thermogravimetric analysis(TGA), inductively coupled plasma(ICP), CHN elemental analysis, nitrogen adsorption-desorption, scanning electron microscope( SEM) and transmission electron microscope(TEM). Ibuprofen(IBU) which contains carboxyl groups was selected as a model drug. The results of drug loading and release reveal that the loading capacities and release behaviors of the model drug are highly dependent on the Ca2+ cations in MSNs. The release of IBU from the MSNs functionalized by Ca2+ cations is found to be effectively controlled when compared to the release from the MSNs without the functionalization of Ca2+ cations, which is due to the ionic interaction between carboxyl groups in IBU and Ca2+ cations in MSNs.
Mesoporous silica nanoparticle / co-Condensation method / Release of ibuprofen / Calcium ion
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
/
| 〈 |
|
〉 |